Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this.

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

Revvity cut its 2024 revenue forecast as reduced biotech spending and a strong dollar weigh on demand for its tools and ...

The founder of Stemregen, a company that creates powerful supplements that stimulate the body’s natural repair system, ...

The chemicals are called EDCs, and they are likely already in your home. Here’s what researchers know about their potential ...

To fill this gap, UCSB Library’s Research Data Services (RDS) department has launched a consultation service to help UCSB ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” third quarter 2024 investor ...

Following its acquisition of Silk Road in September, Boston Scientific said it plans to consolidate the company’s work in ...

Thermo Fisher Scientific Inc.'s Q3 results demonstrated some end-market stability, particularly in the life science market.

The company's expertise in translating scientific innovations into commercial products is expected to accelerate the journey ...

Enhancing healthcare research, Sapio Sciences' solutions unify lab data management, leveraging AI to improve efficiency and ...

Good morning and welcome to the Boston Scientific Third Quarter 2024 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an ...